MicroStrategy
MSTR
Coinbase
COIN
MARA Holdings
MARA
Meta Platforms
META
NVIDIA
NVDA
US Stock MarketDetailed Quotes
CRSP CRISPR Therapeutics
- 42.430
- +1.410+3.44%
Close Jan 6 16:00 ET
- 42.930
- +0.500+1.18%
Post 20:01 ET
3.62BMarket Cap-15.21P/E (TTM)
44.280High41.210Low2.43MVolume41.250Open41.020Pre Close104.36MTurnover2.90%Turnover RatioLossP/E (Static)85.35MShares91.10052wk High1.87P/B3.56BFloat Cap38.20052wk Low--Dividend TTM83.93MShs Float220.200Historical High--Div YieldTTM7.48%Amplitude11.630Historical Low42.939Avg Price1Lot Size
CRISPR Therapeutics Stock Analyst Ratings & Price Target
Price Target
Updated: Dec 31, 2024
The average CRISPR Therapeutics stock price target is 67.94 with a max estimate of 105.00 and a min estimate of 30.00
Review CRISPR Therapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
Updated: Dec 31, 2024
